Aclaris Therapeutics, Inc. Conversion of Stock, Shares Issued
Aclaris Therapeutics, Inc. (ACRS) had Conversion of Stock, Shares Issued of 11.68 million shares as of 2015-10-13, per its 10-Q filed 2016-11-03.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesIssued1 · last filed 2016-11-03
- 2015-10-13: Conversion of Stock, Shares Issued 11.68M shares.
| Period end | Conversion of Stock, Shares Issued |
|---|---|
| 2015-10-13 | 11.68M shares 10-Q · filed 2016-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |